Dysregulated immune function is a hallmark of lung cancer and COPD, with both diseases sharing similar inflammatory cell profiles characterized by macrophages, neutrophils, and CD4+ and CD8+ lymphocytes. This evidence concerns the gene CD4 and lung carcinoma.